-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Docusign, Lowers Price Target to $75

Benzinga·12/05/2025 16:31:52
Listen to the news
UBS analyst Karl Keirstead maintains Docusign (NASDAQ:DOCU) with a Neutral and lowers the price target from $85 to $75.